Member Info for Retireby40

I’ve changed my mind and reckon we get an RNS on Monday. I’m playing 2 rounds of golf with lunch in between and several times there have been RNSs when I play golf (which isn’t that often) and people I play with moan as I’m always checking the share price on my phone.

Yeah good spot indeed and fingers crossed for Monday. If not I’m sure it’ll be soon enough.

Given MHRA office hours 10am to 4pm surely the likelihood is that it’s Mologic’s or else we would have had an RNS.

It could be our test but it could also be Mologic’s own test.

They wouldn’t have have had a Covid test registered in 2019.

Our live offering has not launched yet as it would need an RNS. I watched the full game and have to confess I didn’t notice. I wasn’t aware they could do that too?

Test test test -
"The effects of long Covid were reported to be affected the day-to-day activities of 650,000 people, with 192,000 of those saying their ability to undertake day-to-day activities had been limited a lot."
That's 1% of our population.
We need to get and keep cases down.

From nicebut on advfn Sng thread -
Prof. Christina Pagel
@chrischirp
Replying to
@chrischirp
Well, 2 doses still v effective BUT 1 dose really is not that effective. This supports the PHE analyses.
BUT also show reducing effectiveness over 3 months out from 2nd dose & worse in older people. And this summer many of our most vulnerable >3 months out from 2nd dose

Yeah so £2.4m Q4 so multiply by 4 would be £9.6m then add £3.6m for MWG orders would be £13.2m and that’s without skintrustclub. £10m not impressive which is why we are stuck where we are. Chinese JV amazing but we need to see revenues. I’m sure the forecast will change but we won’t move a lot until it does. Am chilled as the share price will move before YE and should be nearer to 100p than 30p is my bet.

See if they move once Panmure moves.

Repetitive maybe but any thoughts why our house broker has been away from the action for days? I bet if we get to 249p on the Ask (where it currently sits) it will move higher so stays away from the action.

During a pandemic I doubt they’ll have a half day on a Friday.

For days now sit on the sidelines. Any thoughts?

Given MWG did £1.7m and DVRG £4.2m we need over £12m for 100% growth and I’m sure we’ll do that. Given we already have £3.6m in MWG orders add £4.2m from last year we only need £2.2m more to get to £10m. Surely we’ll be nearer to £20m than £10m and that’s without MicrotoxPD revenues.

The Chinese deal should be transformational. Hopefully a busy end to the month.

I heard we’re not close to herd immunity.

Is due this month, I appreciate it’s more complicated with the MWG acquisition so understandable it’s taking its time. What I hope to see are some decent KPIs and transparency in the divisions so a detailed breakdown. Clearly a post YE update needed too!

Surely the consensus is an intraday more likely than a 7am RNS as we are likely to get emails from bodies in working hours. I guess the same should apply to contract RNSs but they often turn up at 7am. News imminent and who knows if could come from the EU first.

I was not trying to imply something negative brewing but thought more likely the opposite. Hopefully an RNS this week and we can move into an even higher share price zone and get Europe travelling with less hassle and expense.

Have been away from the action (as noted on advfn) for a while now. Reading too much into it or something brewing?

ODX 93.2% with CT <25.
Ours is much better and with lower viral load.
However, there is a growing consensus that a viral load as measured by PCR of Ct<27 should be considered as infectious. The clinical data for Avacta’s AffiDX® SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity for identifying infectious individuals in this range.